HLA-G: A New Immune Checkpoint in Cancer?
Open Access
- 25 June 2020
- journal article
- editorial
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (12), 4528
- https://doi.org/10.3390/ijms21124528
Abstract
Human leukocyte antigen G (HLA-G), known as a central protein in providing immune tolerance to the fetus in pregnant women, is also studied for a possible role in tumor development. Many studies have claimed HLA-G as a new immune checkpoint in cancer. Therefore, HLA-G and its receptors might be targets for immune checkpoint blockade in cancer immunotherapy. In order to substantiate that HLA-G is indeed an immune checkpoint in cancer, two important questions need to be answered: (1) To what extent is HLA-G expressed in the tumor by cancer cells? and (2) What is the function of HLA-G in cancer immune evasion? In this review, we discuss these questions. We agree that HLA-G is a potentially new immune checkpoint in cancer, but additional evidence is required to show the extent of intra-tumor and inter-tumor expression. These studies should focus on tumor expression patterns of the seven different HLA-G isoforms and of the receptors for HLA-G. Furthermore, specific roles for the different HLA-G isoforms should be established.This publication has 69 references indexed in Scilit:
- Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodelingProceedings of the National Academy of Sciences of the United States of America, 2012
- CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosisBlood, 2012
- HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer PatientsThe Journal of Immunology, 2010
- The immunologic constant of rejectionTrends in Immunology, 2008
- HLA-G: from biology to clinical benefitsTrends in Immunology, 2008
- HLA-G expression in human ovarian carcinoma counteracts NK cell functionAnnals of Oncology, 2007
- Trogocytosis-based generation of suppressive NK cellsThe EMBO Journal, 2007
- Residues Met76 and Gln79 in HLA-G α1 domain involved in KIR2DL4 recognitionCell Research, 2005
- The 4H84 monoclonal antibody detecting β2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytesHuman Immunology, 2004
- Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory PotentialThe Journal of Experimental Medicine, 2003